Immunotherapy in ALL: An Expert Exploration of Practice-Changing Findings

Explore practice-changing data on immunotherapies that leverage the immune system to fight ALL with this CME-certified text module and accompanying downloadable slideset!

Amir Fathi, MD


Get up to date on how immunotherapies, such as BiTE constructs and CAR T-cells, are greatly improving outcomes for patients with B-cell ALL.

Amir Fathi, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: November 12, 2018 Expiration: November 11, 2019

Downloadable Slideset

In this expert-authored downloadable slideset, review how to optimize ALL treatment strategies and manage adverse events with BiTE constructs and CAR T-cell therapies.

Amir Fathi, MD Released: November 12, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by an educational funding donation provided by

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?